Picture of Torrent Pharmaceuticals logo

TORNTPHARM — Torrent Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Torrent Pharma misses quarterly estimates on Brazil currency depreciation

May 20 (Reuters) - Indian drugmaker Torrent Pharmaceuticals TORP.NS missed fourth-quarter profit and revenue estimates on Tuesday, hurt by currency depreciation in Brazil, its top overseas market by revenue.

The company reported consolidated net profit of 4.98 billion rupees ($58.2 million) for January-March quarter, up 11% from a year earlier. Analysts, on average, expected a profit of 5.19 billion rupees, according to data compiled by LSEG.

Revenue from operations rose 8% to 29.59 billion rupees, compared with analysts' average estimate of 29.85 billion rupees.

For further earnings highlights, click nFWN3RR2ZY

KEY CONTEXT

Torrent had flagged earlier this year that revenues are declining in Brazil — its biggest overseas market by revenue, followed by Germany and the U.S. — due to steep depreciation of the real.

A hit from the weakening currency overshadowed the boost from resuming insulin shipments from its Gujarat facility it shuttered last August for maintenance purposes.

In India, Torrent's biggest market by revenue and where it competes with peers such as Mankind Pharma MNKI.NS, it has benefited from steady demand for its specialty and chronic illness drugs.

Torrent offers drugs used to treat cancer, infections and diabetes.

PEER COMPARISON

Estimates (next 12 months)Analysts' sentiment
RICPEEV/EBITDARevenue growth (%)Profit growth (%)Mean rating*# of analystsStock to price target**
Torrent Pharmaceuticals LtdTORP.NS43.6425.5413.0731.19Hold240.94
Mankind Pharma LtdMNKI.NS46.7724.3322.1915.18Buy130.92
Glenmark Pharmaceuticals LtdGLEN.NS23.1513.6211.8024.48Buy90.86
Sun Pharmaceutical Industries LtdSUN.NS30.8622.9010.8513.55Buy310.85
* The mean of analyst ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell ** The ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is trading above the PT JANUARY-MARCH STOCK PERFORMANCE -- All data from LSEG -- $1 = 85.5660 Indian rupees TORP Q4 https://tmsnrt.rs/4jcx0ka (Reporting by Hritam Mukherjee and Nandan Mandayam in Bengaluru; Editing by Sahal Muhammed) ((Hritam.Mukherjee@thomsonreuters.com; Twitter: @MukherjeeHritam;))

Recent news on Torrent Pharmaceuticals

See all news